Elcatonin
CAS: 60731-46-6
AA-Sequence:
H-DL-Ser(1)-DL-Asn-DL-Leu-DL-Ser-DL-xiThr-DL-Asu(1)-DL-Val-DL-Leu-Gly-DL-Lys-DL-Leu-DL-Ser-DL-Gln-DL-Glu-DL-Leu-DL-His-DL-Lys-DL-Leu-DL-Gln-DL-xiThr-DL-Tyr-DL-Pro-DL-Arg-DL-xiThr-DL-Asp-DL-Val-Gly-DL-Ala-Gly-DL-xiThr-DL-Pro-NH2
Originator: Asahi Kasei Pharma Corp
First marketed by: Asahi Kasei Pharma Corp
Name of FDF: Elcitonin®
Original FDF: RTU solution for subcutaneous or intramuscular injection
Mode of Action
Calcitonin derivative used as an anti-parathyroid agent.
Indications
It is used for remitting or eliminating pain caused by osteoporosis
Patent status
Generic products are available